New immunotherapy in the initial setting shows improved outcomes in ALL
Prior treatment for newly diagnosed acute lymphoblastic leukemia (ALL) in adults has included multiple chemotherapy regimens for several decades, and has induced remission in most patients.1 Unfortunately, these remissions are usually not long-lasting, and many patients eventually relapse and require additional treatment.2-4 Since 2010, several new highly active therapies have been approved for relapsed ALL, …
New immunotherapy in the initial setting shows improved outcomes in ALL Read More »